Phase 4
Completed N=97
Patient Education in Adherence on Acne (PEAce)
Source: ClinicalTrials.gov NCT02307266 ↗Enrolled (actual)
97
Serious AEs
0.0%
Results posted
Sep 2016
Primary outcomePrimary: Mean Rate of Adherence, as Assessed by Medical Event Monitoring System (MEMS) — 63.1; 56.5; 48.2 percentage of adherence — p=0.3165
◆ Published Evidence
Established
▲ Trending
20citations · ~2 / year
Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study.
Summary
This is a multi-center, randomised and controlled study in subjects with acne vulgaris. The main objective of this study is to evaluate the effect of a supplementary patient education intervention (in addition to the standard-of-care patient education) on treatment adherence and satisfaction among acne patients receiving once-daily EpiduoTM gel treatment in primary care clinics.
Linked Publications
-
Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Rate of Adherence, as Assessed by Medical Event Monitoring System (MEMS) |
63.1; 56.5; 48.2 | 0.3165 |
Eligibility Criteria
Inclusion Criteria
- Male or female subjects age of 12 years or older,
- With facial acne vulgaris that can be managed in primary care
Exclusion Criteria
- Female subjects who are pregnant, nursing or planning a pregnancy during the study,
- Subjects have a very severe variant of acne such as fulminating acne with systemic symptoms (acne fulminans)
Data sourced from ClinicalTrials.gov (NCT02307266) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.